French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort)

NACompletedINTERVENTIONAL
Enrollment

1,005

Participants

Timeline

Start Date

November 22, 2018

Primary Completion Date

June 5, 2025

Study Completion Date

June 5, 2025

Conditions
NAFLD
Interventions
DIAGNOSTIC_TEST

biopsy-proven NAFLD patients with non-invasive tests of liver fibrosis (blood tests, elastography devices) and biobank

To evaluate and improve the non-invasive diagnosis of liver fibrosis in NAFLD and to develop the non-invasive diagnosis of NASH

Trial Locations (16)

Unknown

Amiens University Hospital, Amiens

University Hospital of Besançon, Besançon

University Hospital of Clermont-Ferrand, Clermont-Ferrand

Grenoble University Hospital, Grenoble

Hospital of Le Havre, Le Havre

University Hospital of Lille, Lille

Hospital Center Of Lorient, Lorient

Edouard Herriot Hospital, Lyon

Saint-Joseph Hospital, Marseille

University Hospital Of Nice, Nice

University of Bordeaux, Pessac

University Hospital of Rouen, Rouen

University Hospital of Strasbourd, Strasbourg

University Hospital of Toulouse, Toulouse

University Hospital Of Nancy, Vandœuvre-lès-Nancy

University Hospital of Pointe à Pitre, Pointe-à-Pitre

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT03695796 - French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort) | Biotech Hunter | Biotech Hunter